TABLE 1.
Studies on predictive values of TMAO for HF clinical outcomes.
Patients | Clinical outcomes | References |
Acute HF patients (n = 972) | In-hospital mortality, all-cause mortality and rehospitalization | Suzuki et al., 2016 |
HFpEF patients (n = 146) | Cardiac-caused mortality and hospitalization | Kinugasa et al., 2021 |
Acute myocardial infarction (AMI)-related HF patients (n = 985) | Major adverse cardiac events (MACE), including all-cause death, MI recurrence and rehospitalization | Li N. et al., 2022 |
Stable HF patients (n = 720) | Mortality | Tang et al., 2014 |
Chronic HF patients (n = 112) | Mortality and heart transplantation | Tang et al., 2015 |
New-onset or progressively worsening HF patients (n = 2234) | Mortality and rehospitalization | Suzuki et al., 2019 |